NPI: 1992047450 · MONTGOMERY, AL 36116 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/22/2013
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/22/2013 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 13,677 | $347K |
| 2019 | 20,050 | $247K |
| 2020 | 15,586 | $231K |
| 2021 | 11,522 | $241K |
| 2022 | 542 | $14K |
| 2023 | 161 | $6K |
| 2024 | 1,286 | $44K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 18,407 | 1,428 | $826K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 20,626 | 1,113 | $255K |
| J1756 | Injection, iron sucrose, 1 mg | 4,764 | 967 | $24K |
| 83970 | 581 | 462 | $8K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 13,680 | 1,149 | $8K |
| A4657 | Syringe, with or without needle, each | 1,028 | 856 | $2K |
| 82108 | 172 | 159 | $1K | |
| 85045 | 776 | 635 | $932.20 | |
| 83550 | 322 | 262 | $823.90 | |
| 82728 | 313 | 258 | $795.91 | |
| 85041 | 876 | 685 | $668.98 | |
| 85048 | 876 | 685 | $622.50 | |
| 83540 | 321 | 261 | $541.10 | |
| 90674 | 15 | 15 | $56.26 | |
| 86706 | 13 | 13 | $29.10 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 54 | 33 | $0.00 |